NCT05877625

Brief Summary

HAI (Hospital-acquired infection) is very common in ICU,and lack of understanding of environmental exposure omics and environment-host microbial interactions restricts the prevention and control of HAI. In this project, the investigators try to analyze the spatial and temporal distribution characteristics and evolution of microorganisms and their functions in the ICU environment through metagenome.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
180

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2022

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

May 17, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 26, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2023

Completed
Last Updated

June 22, 2023

Status Verified

May 1, 2023

Enrollment Period

12 months

First QC Date

May 17, 2023

Last Update Submit

June 20, 2023

Conditions

Keywords

Environment exposureMicrobial ColonizationMicrobiome

Outcome Measures

Primary Outcomes (1)

  • Community of microbiome in ICU

    the dynamic changes of metagenomic/16s sequencing data

    1 year

Study Arms (3)

open ICU

open ICU: open ICU

Procedure: Expectoration care

negative ICU

negative ICU: negative-pressure laminar flow ward

Procedure: Expectoration care

positive ICU

positive ICU: laminar flow ward

Procedure: Expectoration care

Interventions

1. Endotracheal aspiration: from discarded samples after expectoration care 2. BALF (bronchoalveolar lavage fluid): if patients with fiber bronchoscope examination, take the rest of the BALF after examination 3. Oropharyngeal swabs

Also known as: Bronchoscope, Oropharyngeal swabs
negative ICUopen ICUpositive ICU

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with mechanical ventilation, age ≥18 years, anticipated ICU stay for more than 2 days, and with two or more of the following ventilator-associated pneumonia (VAP) risk factors were included in this study.

You may qualify if:

  • With mechanical ventilation
  • Age ≥18 years
  • Anticipated ICU stay for more than 2 days
  • With two or more of the following ventilator-associated pneumonia (VAP) risk factors
  • VAP risk factors: Age ≥ 60 years old; Patients with chronic lung disease; Long-term bedridden; Unconsciousness; Sputum is not easily coughed up; Antibiotics have been used before mechanical ventilation; Long-term use of H receptor blockers and proton pump inhibitors.

You may not qualify if:

  • Patients who have not signed the informed consent
  • Pregnant
  • Systemic diseases and recent use of related drugs
  • History of infectious diseases, such as tuberculosis or PPD positive
  • History of hypertension and poor blood pressure control (SBP / DBP \> = 140mmHg)
  • With severe mental illness
  • Long term use of traditional Chinese medicine, probiotics, gastric mucosal protective agents, proton pump inhibitors, chemotherapy or immunosuppressive drugs, etc.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Peking University Third Hospital

Beijing, Beijing Municipality, 100191, China

Location

Biospecimen

Retention: SAMPLES WITH DNA

endotracheal aspiration, bronchoalveolar lavage fluid

MeSH Terms

Conditions

Cross InfectionPneumonia, Ventilator-AssociatedCommunicable Diseases

Interventions

Bronchoscopes

Condition Hierarchy (Ancestors)

InfectionsIatrogenic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsHealthcare-Associated PneumoniaPneumoniaRespiratory Tract InfectionsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

EndoscopesDiagnostic EquipmentEquipment and SuppliesSurgical Equipment

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
90 Days
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 17, 2023

First Posted

May 26, 2023

Study Start

August 1, 2022

Primary Completion

July 31, 2023

Study Completion

August 31, 2023

Last Updated

June 22, 2023

Record last verified: 2023-05

Locations